The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer.

Antiviral Research
Sundy N Y YangDavid A Jans

Abstract

Infection by RNA viruses such as human immunodeficiency virus (HIV)-1, influenza, and dengue virus (DENV) represent a major burden for human health worldwide. Although RNA viruses replicate in the infected host cell cytoplasm, the nucleus is central to key stages of the infectious cycle of HIV-1 and influenza, and an important target of DENV nonstructural protein 5 (NS5) in limiting the host antiviral response. We previously identified the small molecule ivermectin as an inhibitor of HIV-1 integrase nuclear entry, subsequently showing ivermectin could inhibit DENV NS5 nuclear import, as well as limit infection by viruses such as HIV-1 and DENV. We show here that ivermectin's broad spectrum antiviral activity relates to its ability to target the host importin (IMP) α/β1 nuclear transport proteins responsible for nuclear entry of cargoes such as integrase and NS5. We establish for the first time that ivermectin can dissociate the preformed IMPα/β1 heterodimer, as well as prevent its formation, through binding to the IMPα armadillo (ARM) repeat domain to impact IMPα thermal stability and α-helicity. We show that ivermectin inhibits NS5-IMPα interaction in a cell context using quantitative bimolecular fluorescence complementation. ...Continue Reading

Citations

Apr 22, 2020·The American Journal of Tropical Medicine and Hygiene·Carlos ChaccourN Regina Rabinovich
Jun 4, 2020·Pathogens·Sabari Nath Neerukonda, Upendra Katneni
May 29, 2020·Naunyn-Schmiedeberg's Archives of Pharmacology·Emanuele Rizzo
May 30, 2020·International Journal of Molecular Medicine·George Mihai NitulescuAristidis Tsatsakis
Sep 26, 2020·Frontiers in Pharmacology·Rudra P SahaChiranjib Chakraborty
Aug 28, 2020·Frontiers in Pharmacology·Malak KaddouraHassan Zaraket
Aug 28, 2020·Frontiers in Public Health·Nour ChamsInaya Hajj Hussein
Jun 1, 2020·Annals of Clinical Microbiology and Antimicrobials·Khan SharunHakan Leblebicioglu
Jul 29, 2020·International Journal of Molecular Sciences·Rami A Al-HoraniKholoud F Aliter
Sep 19, 2020·Cells·David A Jans, Kylie M Wagstaff
Jun 11, 2020·Journal of the Chinese Medical Association : JCMA·Yung-Hung LuoYuh-Min Chen
Aug 6, 2020·Frontiers in Cell and Developmental Biology·Md Tanvir KabirLotfi Aleya
Apr 16, 2020·International Journal of Molecular Sciences·Yung-Fang TuShih-Hwa Chiou
Aug 7, 2020·International Journal of Molecular Sciences·Sareh ZhandMark W Douglas
May 13, 2020·Current Pharmacology Reports·Renyi WuAh-Ng Kong
Oct 7, 2020·Viral Immunology·Camilla M DonnellyJade K Forwood
Oct 13, 2020·Frontiers in Medicine·Amélia Carolina Lopes FernandesEduardo Pereira de Azevedo
Oct 17, 2020·Curēus·Karim O ElkholyHesham Abowali
Oct 29, 2020·Journal of Biomolecular Structure & Dynamics·Parth Sarthi Sen GuptaMalay Kumar Rana
Oct 31, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eng Eong Ooi
Nov 3, 2020·Journal of Biomolecular Structure & Dynamics·Faizul AzamM U Khan
Oct 20, 2020·Journal of Medical Virology·Charles W StrattonHongzhou Lu
Nov 21, 2020·Expert Review of Respiratory Medicine·Atieh YaghoubiSaman Soleimanpour
Jan 4, 2021·Pharmacological Reports : PR·Anurag Singh, Vandana Gupta
Jul 1, 2020·European Journal of Pharmacology·Giulio NittariSeyed Khosrow Tayebati
Jan 14, 2021·Biochemical Society Transactions·Alexander J Martin, David A Jans
Dec 11, 2020·Antiviral Research·Paul T WinnardVenu Raman
Nov 1, 2020·Drug Discovery Today·Jose J NavejaKarina Martinez-Mayorga
Jan 6, 2021·The FEBS Journal·Chun-Chi ChenRey-Ting Guo
Jan 26, 2021·Journal of Pharmaceutical Sciences·Jorge ErrecaldeCarlos Lanusse
Dec 22, 2020·Expert Opinion on Drug Discovery·Carolina L BelleraAlan Talevi
Oct 30, 2020·Infection and Drug Resistance·Raphael B Stricker, Melissa C Fesler
Jan 15, 2021·Journal of Experimental Pharmacology·Pasquale PaglianoAmelia Filippelli
Jan 12, 2021·Indian Journal of Clinical Biochemistry : IJCB·Himani RathiManisha Naithani
Feb 13, 2021·International Journal of Molecular Sciences·Hyung Muk ChoiKyoung Soo Kim
Dec 21, 2020·Biochemical and Biophysical Research Communications·David A Jans, Kylie M Wagstaff
Oct 11, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fabio Rocha FormigaLindomar Pena

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.